Unknown

Dataset Information

0

JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.


ABSTRACT: Our previous study showed that activation of c-jun-N-terminal kinase (JNK) in spinal astrocytes plays an important role in neuropathic pain sensitization. We further investigated how JNK regulates neuropathic pain. In cultured astrocytes, tumor necrosis factor alpha (TNF-alpha) transiently activated JNK via TNF receptor-1. Cytokine array indicated that the chemokine CCL2/MCP-1 (monocyte chemoattractant protein-1) was strongly induced by the TNF-alpha/JNK pathway. MCP-1 upregulation by TNF-alpha was dose dependently inhibited by the JNK inhibitors SP600125 (anthra[1,9-cd]pyrazol-6(2H)-one) and D-JNKI-1. Spinal injection of TNF-alpha produced JNK-dependent pain hypersensitivity and MCP-1 upregulation in the spinal cord. Furthermore, spinal nerve ligation (SNL) induced persistent neuropathic pain and MCP-1 upregulation in the spinal cord, and both were suppressed by D-JNKI-1. Remarkably, MCP-1 was primarily induced in spinal cord astrocytes after SNL. Spinal administration of MCP-1 neutralizing antibody attenuated neuropathic pain. Conversely, spinal application of MCP-1 induced heat hyperalgesia and phosphorylation of extracellular signal-regulated kinase in superficial spinal cord dorsal horn neurons, indicative of central sensitization (hyperactivity of dorsal horn neurons). Patch-clamp recordings in lamina II neurons of isolated spinal cord slices showed that MCP-1 not only enhanced spontaneous EPSCs but also potentiated NMDA- and AMPA-induced currents. Finally, the MCP-1 receptor CCR2 was expressed in neurons and some non-neuronal cells in the spinal cord. Together, we have revealed a previously unknown mechanism of MCP-1 induction and action. MCP-1 induction in astrocytes after JNK activation contributes to central sensitization and neuropathic pain facilitation by enhancing excitatory synaptic transmission. Inhibition of the JNK/MCP-1 pathway may provide a new therapy for neuropathic pain management.

SUBMITTER: Gao YJ 

PROVIDER: S-EPMC2682921 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.

Gao Yong-Jing YJ   Zhang Ling L   Samad Omar Abdel OA   Suter Marc R MR   Yasuhiko Kawasaki K   Xu Zhen-Zhong ZZ   Park Jong-Yeon JY   Lind Anne-Li AL   Ma Qiufu Q   Ji Ru-Rong RR  

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090401 13


Our previous study showed that activation of c-jun-N-terminal kinase (JNK) in spinal astrocytes plays an important role in neuropathic pain sensitization. We further investigated how JNK regulates neuropathic pain. In cultured astrocytes, tumor necrosis factor alpha (TNF-alpha) transiently activated JNK via TNF receptor-1. Cytokine array indicated that the chemokine CCL2/MCP-1 (monocyte chemoattractant protein-1) was strongly induced by the TNF-alpha/JNK pathway. MCP-1 upregulation by TNF-alpha  ...[more]

Similar Datasets

| S-EPMC9826442 | biostudies-literature
| S-EPMC3408211 | biostudies-literature
| S-EPMC4184558 | biostudies-literature
| S-EPMC3702283 | biostudies-literature
| S-EPMC3721848 | biostudies-literature
| S-EPMC8118694 | biostudies-literature
| S-EPMC4718109 | biostudies-other
| S-EPMC3899784 | biostudies-literature
| S-EPMC4107738 | biostudies-literature
| S-EPMC6670070 | biostudies-literature